The Biologic Basis of Clinical Heterogeneity in Juvenile Idiopathic Arthritis

E-ISSN： 2326-5205|66|12|3463-3475

ISSN： 2326-5191

Source： ARTHRITIS & RHEUMATOLOGY, Vol.66, Iss.12, 2014-12, pp. : 3463-3475

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis

By Klein Ariane Horneff Gerd

Clinical Investigation, Vol. 3, Iss. 5, 2013-05 ,pp. : 493-504

Future Science

Access to resources Recommend Favorite

Efficacy and Safety of Adalimumab as the First and Second Biologic Agent in Juvenile Idiopathic Arthritis: The German Biologics JIA Registry

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 9, 2014-09 ,pp. : 2580-2589

John Wiley & Sons Inc

Access to resources Recommend Favorite

Towards a role of ultrasound in children with juvenile idiopathic arthritis

By Lanni Stefano

British Journal of Rheumatology , Vol. 52, Iss. 3, 2013-03 ,pp. : 413-420

Oxford University Press

Access to resources Recommend Favorite

Prevalence of sinonasal disease in children with Juvenile idiopathic arthritis

THE LARYNGOSCOPE, Vol. 125, Iss. 2, 2015-02 ,pp. : 291-295

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sibling Exposure and Risk of Juvenile Idiopathic Arthritis

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 7, 2015-07 ,pp. : 1951-1958

John Wiley & Sons Inc

Access to resources Recommend Favorite